GlassScriptPhysician profile
Bryan J Robins
NPI 1023549938
$3,764.61
in general payments reported to CMS, 2019-2025
10 companies · $36.81 in 2025
The $36.81 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,460 · 2024: $2,267 · 2025: $36.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,011 · Food and Beverage: $1,653 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,010.58 |
| Food and Beverage | $1,653.31 |
| Education | $100.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,613.15 | 2023-2024 | Da Vinci Surgical System |
| Thd America, INC. | $836.31 | 2023 | |
| W. L. Gore & Associates, INC. | $500.31 | 2023-2024 | Gore Enform Preperitoneal Biomaterial, Seamguard, Gore Synecor Biomaterial |
| Medtronic, INC. | $217.31 | 2023 | Interstim, Ligasure |
| Baxter Healthcare | $148.45 | 2024 | Perclot |
| Ethicon US, LLC | $121.03 | 2023 | Vistaseal, Monocryl |
| Stryker Corporation | $117.64 | 2024 | Spy-Phi System, 1788, Switchpoint Infinity, Isuite |
| Tela Bio, INC. | $93.33 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Activ Surgical, INC. | $80.27 | 2024 | Activsight |
| Solventum Corporation | $36.81 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Robins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.